| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |